Politician trade (Senate)

Abbott Laboratories (ABT): Sen. Thomas R Carper disclosed a purchase $1K–$15K

Sen. Thomas R Carper disclosed a purchase of Abbott Laboratories in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
17 days
Disclosure lag
Traded
Oct 17, 2022
Disclosed
Nov 3, 2022

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 4, 2021CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  2. Sep 21, 2022CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  3. Oct 17, 2022 · this disclosureCongressDisclosed purchase of ABT — reported range $1,001 - $15,000

What came next

  1. Oct 21, 2022CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  2. Feb 9, 2023FDARecall: FreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 Operating System
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 70 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Sen. Thomas R Carper

The full history of Sen. Thomas R Carper is on the profile page.

How this filing works

Explore the data

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data